According To Rosenthal Burchum 2022: Drug Reactions

According To Rosenthal Burchum 2022 The Reaction Of Drugs In The B

According to Rosenthal and Burchum (2022), the reaction of drugs in the body is described through two key processes: pharmacokinetics and pharmacodynamics. Pharmacokinetics involves the movement of the drug through the body, often summarized by the acronym ADME—Absorption, Distribution, Metabolism, and Excretion—highlighting how the body affects the drug. Pharmacodynamics, on the other hand, refers to the biological and physiological effects of drugs on the body, including the mechanisms of action and the relationship between drug concentration and effect. Understanding these processes is fundamental in clinical practice to optimize drug therapy and minimize adverse effects.

In clinical settings, there are multiple instances where the expected therapeutic outcomes are not achieved, necessitating an understanding of pharmacokinetic and pharmacodynamic principles. The case of a 75-year-old woman hospitalized with pneumonia exemplifies this challenge. Despite being prescribed antibiotics, she exhibited persistent symptoms such as fever, cough, and shortness of breath. Laboratory investigations revealed her blood levels of the antibiotic were particularly low, leading clinicians to examine how aging might influence drug handling.

It is known that aging significantly impacts pharmacokinetic and pharmacodynamic processes. As individuals age, physiological changes such as decreased hepatic and renal functions occur. The liver's capacity to metabolize drugs diminishes, partly due to reduced hepatic blood flow and decreased activity of drug-metabolizing enzymes. Consequently, drugs that rely heavily on hepatic metabolism, like many antibiotics, may have decreased clearance, resulting in lower blood concentrations (Balaram & Balachandran, 2022). Additionally, age-related changes include an increased percentage of body fat and reduced lean body mass, which alter drug distribution, especially for lipophilic medications.

Gender differences also influence drug response. Women generally have a higher body fat percentage and lower lean mass, impacting drug distribution. Hormonal fluctuations during menstrual cycles may further affect drug metabolism and clearance; however, in elderly women, these effects are less pronounced but still noteworthy. Diet is another critical factor affecting pharmacokinetics. For instance, certain foods like grapefruit juice can inhibit cytochrome P450 enzymes—particularly CYP3A4—leading to increased drug levels. In contrast, some foods may decrease drug absorption or alter pharmacokinetics, emphasizing the importance of dietary assessments in drug therapy management.

Pathophysiological changes associated with diseases like pneumonia can further influence pharmacokinetic and pharmacodynamic processes. The inflammatory response can impair hepatic blood flow and enzyme activity, reducing drug metabolism. Renal impairment, common in elderly patients, also compromises elimination, leading to drug accumulation and toxicity risk (Parnham & Kricker, 2022). Therefore, understanding these changes is vital for dose adjustment and personalized therapy to attain optimal therapeutic levels while minimizing adverse effects.

Implementing a personalized plan of care is fundamental in managing such complex cases. Therapeutic drug monitoring (TDM) becomes essential, especially when initial therapy fails or when dealing with drugs with narrow therapeutic windows. Regular blood level assessments guide dose adjustments, ensuring therapeutic effectiveness. In this case, the low antibiotic levels prompted a reevaluation of dosing, considering modified pharmacokinetics due to age-related organ function decline.

Adjusting dosages in elderly patients requires careful consideration of individual variables, including age, organ function, comorbidities, and concurrent medications. Reduced doses or extended dosing intervals may be necessary to prevent toxicity while maintaining efficacy. For example, since hepatic metabolism is compromised, drugs metabolized by the liver need dose reductions to prevent accumulation. Individualized dosing regimens, supported by TDM results, are central to achieving optimal concentrations (Isitan & Hohler, 2017).

Patient education is equally important. Ensuring the patient understands the importance of medication adherence, including correct timing and dosage, enhances therapeutic success. Patients should also be informed about potential side effects and when to seek medical attention. In this scenario, educating the patient about the reasons for monitoring drug levels and possible adjustments helps foster cooperation and compliance.

Furthermore, a multidisciplinary approach involving physicians, pharmacists, nurses, and other healthcare professionals enhances patient care. Collaboration facilitates comprehensive assessment of the patient's condition, medication appropriateness, and response, while promoting adjustment strategies based on ongoing monitoring. Addressing underlying health conditions, such as pneumonia, with complementary therapies like respiratory support and physiotherapy, improves overall outcomes.

In conclusion, age-related physiological changes significantly influence the pharmacokinetic and pharmacodynamic responses to medications. The case discussed underscores the importance of individualized therapy, therapeutic drug monitoring, patient education, and multidisciplinary collaboration in ensuring effective and safe medication management for elderly patients. Recognizing these factors allows healthcare providers to optimize treatment, reduce toxicity, and improve recovery rates.

References

• Balaram, K., & Balachandran, S. (2022). Psychopharmacology in the Elderly: Why Does Age Matter? Psychiatric Clinics.
• Hohler, A. D. (2017). Cefepime induced neurotoxicity: A case series and review of the literature. Eneurologicalsci, 8, 40–43.
• Le, J. (2019). Overview of pharmacokinetics. Merck Manual. Retrieved from https://www.merckmanuals.com
• Parnham, M. J., & Kricker, J. A. (2022). Factors determining plasticity of responses to drugs. International Journal of Molecular Sciences, 23(4), 2068.
• Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.). Elsevier.
• Smith, H., et al. (2018). Impact of age-related changes on drug pharmacokinetics and pharmacodynamics. Journal of Geriatric Pharmacotherapy, 12(3), 200–210.
• Sharma, S., & Singh, S. (2020). Personalized medicine in elderly patients: Pharmacokinetic considerations. Advances in Pharmacology, 85, 67–87.
• Weiss, S. T., & DiPiro, J. T. (2014). Pharmacokinetics and pharmacodynamics. In Pharmacotherapy: A Pathophysiologic Approach (9th ed.). McGraw-Hill Education.
• Wilson, J. G. (1966). Theounderstanding of drug metabolism and interactions in elderly patients. Clinical Pharmacology & Therapeutics, 7(4), 532–543.
• Zhou, S., et al. (2009). Inter-individual variability in drug metabolism and response. Pharmacogenomics, 10(2), 281–293.